ARCHIVES

FDA Says Medicare Policy On ESAs “Consistent With The Available Data.”

This article is from The Cancer Letter archive.

Vol. 33 No. 38 | October 19, 2007

Download PDF Visit The Full Archive

Related Articles

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008

Also in this 8-page issue: House Committee on Energy and Commerce is investigating the collapse of the Institute for Cancer Prevention, which owes $5.7 million to NCI.

December 3, 2004

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

July 25, 2008

In Brief: Cancer Panel To Meet In Seattle, Houston, Chicago; Wisconsin’s Robert Johnson Dies; Goldin Retires

August 27, 1982

California approves $3 billion program for stem-cell research.

November 5, 2004

DCT Board Approves New Task Orders For RMP Clinical Trials, Holds Up On Additional Grants

February 20, 1981